| BD BACTEC FX, Instrument Top, Packaged
Version or Model: 441385
Catalog Number: 441385Z-0593-2025 · MDB | Becton Dickinson & Co. | Recall | Dec 3, 2024FDA classification date |
| BD BACTEC FX40 Instrument
Version or Model: 442296
Catalog Number: 442296Z-0594-2025 · MDB | Becton Dickinson & Co. | Recall | Dec 3, 2024FDA classification date |
| BACTEC 9120 System
Version or Model: 445570
Catalog Number: 445570Z-0595-2025 · MDB | Becton Dickinson & Co. | Recall | Dec 3, 2024FDA classification date |
| BACTEC 9240 System
Version or Model: 445475
Catalog Number: 445475Z-0596-2025 · MDB | Becton Dickinson & Co. | Recall | Dec 3, 2024FDA classification date |
| BD Synapsys Informatics Solution with software versions: 4.20, 4.30, 5.10, 5.20 and 5.30-
IVD standalone laboratory software solution providing d…Z-0026-2025 · JQP | Becton Dickinson & Co. | Recall | Oct 8, 2024FDA classification date |
| BD Phoenix M50 instrument -Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant ba…Z-3246-2024 · LON | Becton Dickinson & Co. | Recall | Sep 24, 2024FDA classification date |
| BD Phoenix 100-Intended for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically significant bacteria. The …Z-3247-2024 · LON | Becton Dickinson & Co. | Recall | Sep 24, 2024FDA classification date |
| BD BACTEC MGIT 960 PZA Kit)- IVD qualitative procedure for susceptibility testing of Mycobacterium tuberculosis, from culture to pyrazinamide (P…Z-2686-2024 · MJA | Becton Dickinson & Co. | Recall | Aug 16, 2024FDA classification date |
| BD Kiestra Urine Culture Application Powered by BD Synapsys Informatics Solution; Catalog (Ref): 444900;Z-2585-2024 · KZB | Becton Dickinson & Co. | Recall | Aug 14, 2024FDA classification date |
| BD SARS-CoV-2 Reagents for BD MAX" Systems. RT-PCR test to detect SARS-CoV-2 in nasal, nasopharyngeal, oropharyngeal swab specimens, and saliva s…Z-2023-2024 · QJR | Becton Dickinson & Co. | Recall | Jun 5, 2024FDA classification date |
| BD Phoenix NMIC-306 Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing c…Z-1398-2024 · LON | Becton Dickinson & Co. | Recall | Mar 29, 2024FDA classification date |
| BD Phoenix Yeast ID Panel is a self-inoculating (when used with a BD Phoenix Automated Microbiology System) polystyrene panel (tray) containing c…Z-1399-2024 · LON | Becton Dickinson & Co. | Recall | Mar 29, 2024FDA classification date |
| Sensi Disc Amoxicillin with Clavulanic Acid 20/10 g, Catalog No. 231628 and 231629.
These discs are used for semi-quantitative in vitro suscept…Z-1011-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ampicillin - 10 g, Catalog No. 230705 and 231264; 2 g, Catalog No. 231263. Used for semi-quantitative in vitro susceptibility t…Z-1012-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ampicillin with Sulbactam 10/10 g, Catalog Number 231660. Used for semi-quantitative in vitro susceptibility testing.Z-1013-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Augmentin - 3g, Catalog Number 291270used for semi-quantitative in vitro susceptibility testing.Z-1014-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Azithromycin -15 g, Catalog Number 231682used for semi-quantitative in vitro susceptibility testing.Z-1015-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Aztreonam - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Numbers 231640and 231641.Z-1016-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefaclor - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231653Z-1017-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefepime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231696Z-1018-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefixime - 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231664Z-1019-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefotaxime - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231606 and 231607;
5 ug, Catalog…Z-1020-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Cefpodoxime - 10 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231673 and 231674Z-1021-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ceftaroline - 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 232231Z-1022-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |
| BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632and 231633Z-1023-2024 · JTN | Becton Dickinson & Co. | Recall | Feb 8, 2024FDA classification date |